下個月改名了,叫Zevra查看全文
黄野仁2023-01-23 21:11
$KemPharm(KMPH)$
kempharm上週兩個消息:T博士離開管理層,重新回到科研前線。以他的業餘管理水平,被視作好消息
其次是Az藥上週腳本超過5400,上市以來新高,開始銷路有點起色查看全文
黄野仁2022-10-24 13:28
$KemPharm(KMPH)$
看看对手AYTU旗下两只多动症药物最新脚本/周:
AYTU Adzenys,week ending/scripts
10/14------------4.880
AYTU Cotempla,week ending/scripts
10/14------------2,740
他的季报是这两个利润:ADHD (Adzenys XR-ODT and Cotempla XR-ODT) net revenue...查看全文
黄野仁2022-05-16 10:16
$KemPharm(KMPH)$ $Orphazyme(ORPH)$
T博士對自己這麽自信?Azstarys銷售還沒上軌道又1700萬買個丹麦生物技术公司 Orphazyme ApS的Arimoclomol?
一直以爲kmph會給別人壓價收購,想不到是他趁生科低潮收購別人。
不過看歷史,T博士這家夥對FDA批准很有心得,他的Apadaz,Azstarys都順利...查看全文
Spica2022-04-20 21:15
回复@黄野仁: SDX I期试验开始给药,股价涨8% $KemPharm(KMPH)$ 网页链接//@黄野仁:回复@Spica:是的,爬波一般般,這麼好的藥。五月份會進入全美最大的unh聯合健康保險,到時再看數據查看全文
$KemPharm, Inc.(KMPH)$ 8-K - Current report Filed: 2018-11-08 AccNo: 0001437749-18-020076 Size: 6 MBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$KemPharm, Inc.(KMPH)$ D - Notice of Exempt Offering of Securities Filed: 2018-11-02 AccNo: 0001434647-18-000002 Size: 14 KB 网页链接
$KemPharm, Inc.(KMPH)$ 美东时间 2018-11-08 盘后 披露财报,预期EPS -0.74 网页链接
$KemPharm, Inc.(KMPH)$ 8-K - Current report Filed: 2018-10-30 AccNo: 0001437749-18-019058 Size: 1 MBItem 1.01: Entry into a Material Definitive AgreementItem 3.02: Unregistered Sales of Equity SecuritiesItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Ex...
$KemPharm, Inc.(KMPH)$ 内部交易: 2018-10-12,VP, Corporate Controller,Sangiovanni Timothy J. ,买入,1500普通股, $2.50
$KemPharm, Inc.(KMPH)$ 内部交易: 2018-10-11,VP, Corporate Controller,Sangiovanni Timothy J. ,买入,1500普通股, $2.55
$KemPharm, Inc.(KMPH)$ 内部交易: 2018-10-12,Chief Business Officer,Johnson Gordon K ,买入,1000普通股, $2.61
$KemPharm, Inc.(KMPH)$ 内部交易: 2018-10-10,Chief Business Officer,Johnson Gordon K ,买入,3000普通股, $2.62
$KemPharm, Inc.(KMPH)$ 内部交易: 2018-10-12,总裁 & CEO,Mickle Travis C ,买入,5000普通股, $2.55
$KemPharm, Inc.(KMPH)$ 内部交易: 2018-10-11,CFO, Secretary & Treasurer,Clifton R. LaDuane ,买入,650普通股, $2.54